Which has higher valuation & earnings, ATRC or TFX?

AtriCure has higher earnings, but lower revenue than Teleflex. AtriCure is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AtriCure $534.53M 3.29 -$11.45M -$0.10 N/A Teleflex $1.99B 2.98 -$905.64M -$22.80 N/A

Is ATRC or TFX more profitable?

AtriCure has a net margin of -0.83% compared to Teleflex's net margin of -35.88%. Teleflex's return on equity of 13.29% beat AtriCure's return on equity. Company Net Margins Return on Equity Return on Assets AtriCure -0.83% 0.29% 0.22% Teleflex -35.88% 13.29% 6.55%

Does the media prefer ATRC or TFX?

In the previous week, Teleflex had 6 more articles in the media than AtriCure. MarketBeat recorded 7 mentions for Teleflex and 1 mentions for AtriCure. Teleflex's average media sentiment score of 0.84 beat AtriCure's score of 0.45 indicating that Teleflex is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AtriCure 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Teleflex 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation & earnings, ATRC or ITGR?

Integer has higher revenue and earnings than AtriCure. AtriCure is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AtriCure $534.53M 3.29 -$11.45M -$0.10 N/A Integer $1.85B 1.76 $102.81M $4.01 23.94

Is ATRC or ITGR more profitable?

Integer has a net margin of 7.64% compared to AtriCure's net margin of -0.83%. Integer's return on equity of 12.83% beat AtriCure's return on equity. Company Net Margins Return on Equity Return on Assets AtriCure -0.83% 0.29% 0.22% Integer 7.64% 12.83% 6.51%

Does the media refer more to ATRC or ITGR?

In the previous week, Integer had 3 more articles in the media than AtriCure. MarketBeat recorded 4 mentions for Integer and 1 mentions for AtriCure. Integer's average media sentiment score of 0.92 beat AtriCure's score of 0.45 indicating that Integer is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AtriCure 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Integer 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ATRC or SMA?

In the previous week, Smartstop Self Storage REIT had 6 more articles in the media than AtriCure. MarketBeat recorded 7 mentions for Smartstop Self Storage REIT and 1 mentions for AtriCure. Smartstop Self Storage REIT's average media sentiment score of 0.96 beat AtriCure's score of 0.45 indicating that Smartstop Self Storage REIT is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AtriCure 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Smartstop Self Storage REIT 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor IART or ATRC?

In the previous week, Integra LifeSciences had 11 more articles in the media than AtriCure. MarketBeat recorded 12 mentions for Integra LifeSciences and 1 mentions for AtriCure. Integra LifeSciences' average media sentiment score of 0.52 beat AtriCure's score of 0.45 indicating that Integra LifeSciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integra LifeSciences 3 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive AtriCure 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has stronger earnings and valuation, ATEC or ATRC?

AtriCure has lower revenue, but higher earnings than Alphatec. AtriCure is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alphatec $764.16M 1.66 -$143.36M -$0.82 N/A AtriCure $534.53M 3.29 -$11.45M -$0.10 N/A

Is ATEC or ATRC more profitable?

AtriCure has a net margin of -0.83% compared to Alphatec's net margin of -15.93%. AtriCure's return on equity of 0.29% beat Alphatec's return on equity. Company Net Margins Return on Equity Return on Assets Alphatec -15.93% -1,183.84% -15.83% AtriCure -0.83% 0.29% 0.22%

Does the media refer more to ATEC or ATRC?

In the previous week, Alphatec had 4 more articles in the media than AtriCure. MarketBeat recorded 5 mentions for Alphatec and 1 mentions for AtriCure. Alphatec's average media sentiment score of 0.85 beat AtriCure's score of 0.45 indicating that Alphatec is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alphatec 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AtriCure 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

AtriCure (ATRC) Competitors

$34.77 -0.18 (-0.52%)

Closing price 04:00 PM Eastern

Extended Trading

$34.78 +0.01 (+0.03%)

As of 04:10 PM Eastern

Compare

ATRC vs. TFX, ITGR, SMA, IART, and ATEC

Should you buy AtriCure stock or one of its competitors? MarketBeat compares AtriCure with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with AtriCure include Teleflex (TFX), Integer (ITGR), Smartstop Self Storage REIT (SMA), Integra LifeSciences (IART), and Alphatec (ATEC). These companies are all part of the "health care equipment" industry.

How does AtriCure compare to Teleflex?

AtriCure (NASDAQ:ATRC) and Teleflex (NYSE:TFX) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, valuation, earnings, analyst recommendations, media sentiment, risk and institutional ownership.

AtriCure presently has a consensus price target of $48.71, indicating a potential upside of 40.10%. Teleflex has a consensus price target of $148.00, indicating a potential upside of 10.17%. Given AtriCure's stronger consensus rating and higher probable upside, analysts plainly believe AtriCure is more favorable than Teleflex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AtriCure	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64
Teleflex	1 Sell rating(s)	5 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.45

99.1% of AtriCure shares are owned by institutional investors. Comparatively, 95.6% of Teleflex shares are owned by institutional investors. 4.0% of AtriCure shares are owned by insiders. Comparatively, 0.7% of Teleflex shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

In the previous week, Teleflex had 6 more articles in the media than AtriCure. MarketBeat recorded 7 mentions for Teleflex and 1 mentions for AtriCure. Teleflex's average media sentiment score of 0.84 beat AtriCure's score of 0.45 indicating that Teleflex is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AtriCure	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Teleflex	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AtriCure has higher earnings, but lower revenue than Teleflex. AtriCure is trading at a lower price-to-earnings ratio than Teleflex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AtriCure	$534.53M	3.29	-$11.45M	-$0.10	N/A
Teleflex	$1.99B	2.98	-$905.64M	-$22.80	N/A

AtriCure has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market. Comparatively, Teleflex has a beta of 0.82, meaning that its stock price is 18% less volatile than the broader market.

AtriCure has a net margin of -0.83% compared to Teleflex's net margin of -35.88%. Teleflex's return on equity of 13.29% beat AtriCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AtriCure	-0.83%	0.29%	0.22%
Teleflex	-35.88%	13.29%	6.55%

Summary

AtriCure beats Teleflex on 10 of the 16 factors compared between the two stocks.

How does AtriCure compare to Integer?

AtriCure (NASDAQ:ATRC) and Integer (NYSE:ITGR) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

AtriCure has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market. Comparatively, Integer has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market.

Integer has a net margin of 7.64% compared to AtriCure's net margin of -0.83%. Integer's return on equity of 12.83% beat AtriCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AtriCure	-0.83%	0.29%	0.22%
Integer	7.64%	12.83%	6.51%

Integer has higher revenue and earnings than AtriCure. AtriCure is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AtriCure	$534.53M	3.29	-$11.45M	-$0.10	N/A
Integer	$1.85B	1.76	$102.81M	$4.01	23.94

In the previous week, Integer had 3 more articles in the media than AtriCure. MarketBeat recorded 4 mentions for Integer and 1 mentions for AtriCure. Integer's average media sentiment score of 0.92 beat AtriCure's score of 0.45 indicating that Integer is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AtriCure	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Integer	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AtriCure currently has a consensus price target of $48.71, suggesting a potential upside of 40.10%. Integer has a consensus price target of $101.14, suggesting a potential upside of 5.38%. Given AtriCure's stronger consensus rating and higher possible upside, analysts plainly believe AtriCure is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AtriCure	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64
Integer	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.27

99.1% of AtriCure shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 4.0% of AtriCure shares are held by insiders. Comparatively, 1.1% of Integer shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

Integer beats AtriCure on 10 of the 17 factors compared between the two stocks.

How does AtriCure compare to Smartstop Self Storage REIT?

AtriCure (NASDAQ:ATRC) and Smartstop Self Storage REIT (NYSE:SMA) are both small-cap health care equipment companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

Smartstop Self Storage REIT has a net margin of 4.38% compared to AtriCure's net margin of -0.83%. Smartstop Self Storage REIT's return on equity of 1.00% beat AtriCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AtriCure	-0.83%	0.29%	0.22%
Smartstop Self Storage REIT	4.38%	1.00%	0.54%

Smartstop Self Storage REIT has lower revenue, but higher earnings than AtriCure. AtriCure is trading at a lower price-to-earnings ratio than Smartstop Self Storage REIT, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AtriCure	$534.53M	3.29	-$11.45M	-$0.10	N/A
Smartstop Self Storage REIT	$281.14M	6.65	-$1.55M	$0.15	225.07

99.1% of AtriCure shares are owned by institutional investors. 4.0% of AtriCure shares are owned by company insiders. Comparatively, 5.7% of Smartstop Self Storage REIT shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

AtriCure presently has a consensus price target of $48.71, suggesting a potential upside of 40.10%. Smartstop Self Storage REIT has a consensus price target of $36.31, suggesting a potential upside of 7.56%. Given AtriCure's higher possible upside, equities research analysts clearly believe AtriCure is more favorable than Smartstop Self Storage REIT.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AtriCure	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64
Smartstop Self Storage REIT	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	2 Strong Buy rating(s)	2.70

In the previous week, Smartstop Self Storage REIT had 6 more articles in the media than AtriCure. MarketBeat recorded 7 mentions for Smartstop Self Storage REIT and 1 mentions for AtriCure. Smartstop Self Storage REIT's average media sentiment score of 0.96 beat AtriCure's score of 0.45 indicating that Smartstop Self Storage REIT is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AtriCure	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Smartstop Self Storage REIT	3 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AtriCure has a beta of 1.24, meaning that its share price is 24% more volatile than the broader market. Comparatively, Smartstop Self Storage REIT has a beta of 0.56, meaning that its share price is 44% less volatile than the broader market.

Summary

Smartstop Self Storage REIT beats AtriCure on 12 of the 17 factors compared between the two stocks.

How does AtriCure compare to Integra LifeSciences?

Integra LifeSciences (NASDAQ:IART) and AtriCure (NASDAQ:ATRC) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, risk, earnings, dividends, media sentiment and analyst recommendations.

In the previous week, Integra LifeSciences had 11 more articles in the media than AtriCure. MarketBeat recorded 12 mentions for Integra LifeSciences and 1 mentions for AtriCure. Integra LifeSciences' average media sentiment score of 0.52 beat AtriCure's score of 0.45 indicating that Integra LifeSciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integra LifeSciences	3 Very Positive mention(s)	1 Positive mention(s)	6 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive
AtriCure	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

AtriCure has lower revenue, but higher earnings than Integra LifeSciences. AtriCure is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integra LifeSciences	$1.64B	0.90	-$516.47M	-$6.46	N/A
AtriCure	$534.53M	3.29	-$11.45M	-$0.10	N/A

Integra LifeSciences has a beta of 1.22, meaning that its stock price is 22% more volatile than the broader market. Comparatively, AtriCure has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market.

84.8% of Integra LifeSciences shares are owned by institutional investors. Comparatively, 99.1% of AtriCure shares are owned by institutional investors. 3.8% of Integra LifeSciences shares are owned by insiders. Comparatively, 4.0% of AtriCure shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

AtriCure has a net margin of -0.83% compared to Integra LifeSciences' net margin of -30.15%. Integra LifeSciences' return on equity of 17.42% beat AtriCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integra LifeSciences	-30.15%	17.42%	5.00%
AtriCure	-0.83%	0.29%	0.22%

Integra LifeSciences currently has a consensus target price of $18.33, suggesting a potential downside of 2.95%. AtriCure has a consensus target price of $48.71, suggesting a potential upside of 40.10%. Given AtriCure's stronger consensus rating and higher possible upside, analysts clearly believe AtriCure is more favorable than Integra LifeSciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integra LifeSciences	2 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	1.86
AtriCure	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64

Summary

AtriCure beats Integra LifeSciences on 11 of the 17 factors compared between the two stocks.

How does AtriCure compare to Alphatec?

Alphatec (NASDAQ:ATEC) and AtriCure (NASDAQ:ATRC) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, analyst recommendations, institutional ownership, risk, media sentiment, valuation, dividends and profitability.

AtriCure has a net margin of -0.83% compared to Alphatec's net margin of -15.93%. AtriCure's return on equity of 0.29% beat Alphatec's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alphatec	-15.93%	-1,183.84%	-15.83%
AtriCure	-0.83%	0.29%	0.22%

AtriCure has lower revenue, but higher earnings than Alphatec. AtriCure is trading at a lower price-to-earnings ratio than Alphatec, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alphatec	$764.16M	1.66	-$143.36M	-$0.82	N/A
AtriCure	$534.53M	3.29	-$11.45M	-$0.10	N/A

Alphatec has a beta of 0.85, suggesting that its stock price is 15% less volatile than the broader market. Comparatively, AtriCure has a beta of 1.24, suggesting that its stock price is 24% more volatile than the broader market.

66.4% of Alphatec shares are held by institutional investors. Comparatively, 99.1% of AtriCure shares are held by institutional investors. 13.5% of Alphatec shares are held by company insiders. Comparatively, 4.0% of AtriCure shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Alphatec had 4 more articles in the media than AtriCure. MarketBeat recorded 5 mentions for Alphatec and 1 mentions for AtriCure. Alphatec's average media sentiment score of 0.85 beat AtriCure's score of 0.45 indicating that Alphatec is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alphatec	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AtriCure	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Alphatec currently has a consensus price target of $17.46, suggesting a potential upside of 111.14%. AtriCure has a consensus price target of $48.71, suggesting a potential upside of 40.10%. Given Alphatec's stronger consensus rating and higher probable upside, equities analysts clearly believe Alphatec is more favorable than AtriCure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alphatec	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	1 Strong Buy rating(s)	2.85
AtriCure	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.64

Summary

Alphatec and AtriCure tied by winning 8 of the 16 factors compared between the two stocks.

Get AtriCure News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ATRC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ATRC vs. The Competition

Export

Metric	AtriCure	MED PRODUCTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.76B	$8.65B	$6.78B	$12.28B
Dividend Yield	N/A	2.49%	2.67%	9.36%
P/E Ratio	-347.70	16.04	27.12	23.98
Price / Sales	3.29	7.08	572.82	112.50
Price / Cash	111.66	18.55	29.05	48.09
Price / Book	3.52	3.26	10.65	6.14
Net Income	-$11.45M	$228.02M	$3.59B	$331.63M
7 Day Performance	-0.09%	-2.84%	-1.61%	-1.68%
1 Month Performance	20.73%	-1.94%	1.01%	-1.40%
1 Year Performance	18.83%	-0.52%	23.83%	17.10%

AtriCure Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ATRC AtriCure	3.5931 of 5 stars	$34.77 -0.5%	$48.71 +40.1%	+19.4%	$1.76B	$534.53M	N/A	1,300	Upcoming Earnings
TFX Teleflex	3.3978 of 5 stars	$129.01 -5.4%	$147.44 +14.3%	+21.4%	$5.71B	$1.99B	N/A	15,500
ITGR Integer	2.5526 of 5 stars	$92.79 -3.7%	$99.29 +7.0%	-15.1%	$3.15B	$1.85B	23.15	11,000	Upcoming Earnings
SMA Smartstop Self Storage REIT	2.6699 of 5 stars	$33.42 +0.8%	$36.81 +10.2%	-4.7%	$1.85B	$281.14M	223.03	N/A
IART Integra LifeSciences	1.5972 of 5 stars	$18.31 -1.5%	$17.17 -6.2%	+73.0%	$1.42B	$1.64B	N/A	4,427	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ATRC) was last updated on 7/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

AtriCure (ATRC) Competitors